2017-2018 Year-In-Review: External Portfolio

By: Douglas Doucette

This year, I began my tenure as Executive Officer taking on the role of President-Elect and External Liaison at the 2017 Fall Board Meeting and AGM held in Fredericton in my home province of New Brunswick. Through the year, I participated in several consultations starting when Myrella Roy, CSHP Executive Director, and I met with Dr. Penny Ballem, Chair, Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada. Myrella Roy, Cathy Lyder (CSHP Director, Members & Programs) and I met with HealthCareCAN to discuss collaboration on a number of advocacy issues, including the opioid crisis, national pharmacare, and antimicrobial resistance. Following the April 2018 Midterm Board Meeting held in Ottawa, Myrella Roy, Cathy Lyder, Sarah Jennings (CSHP Professional Affairs Associate), and I were joined by Linda Vaillant, Executive Director of the Association des pharmaciens des établissements de santé du Québec (APES), and Francois Paradis, APES President, for a series of meetings in the Ottawa area with Health Canada (Health Products and Food Branch, Special Access Programme), Accreditation Canada/Health Standards Organization, and the National Association of Pharmacy Regulatory Authorities. This day was historic in that the CSHP and APES leaders were acting on their recently renewed strategic alliance to present a united voice of Canadian hospital pharmacy. With Health Canada, CSHP and APES discussed opportunities to collaborate on national initiatives to support the World Health Organization’s Global Patient Safety Challenge on medication safety and the mandatory reporting of serious adverse drug reactions by healthcare institutions, and learned of the renewal underway in the Special Access Programme.

CSHP responded to an invitation from the Advisory Council on the Implementation of National Pharmacare to recommend CSHP members who could speak authoritatively about pharmacare and represent CSHP’s position in a series of cross-Canada roundtables last summer. Of the 33 members recommended by CSHP, 14 were invited by the Advisory Council to 9 roundtables. I was privileged to be invited to the first such roundtable held in Fredericton, where I joined various provincial leaders of associations and advocacy groups to share ideas and views on national pharmacare. The Advisory Council’s final report is expected in the spring of 2019.

At the CSHP Midterm Board Meeting in April 2018, our Executive Director, Myrella Roy, announced her intent to retire at the end of December 2018. At the meeting, the Board appointed me as Chair of the CSHP Executive Director Search and Selection Task Force. Subsequently, the decision was made to change the title from Executive Director to Chief Executive Officer, in keeping with the growing practice of many national not-for-profit associations. The Search and Selection Task Force was comprised of current (Patrick Fitch, Zack Dumont, Dawn Jennings) and past Board members (Christina Adams, Bruce Millin), and CSHP employees (Cathy Lyder, Rosemary Pantalone). The national job posting resulted in over 30 applications from which the Task Force selected 5 persons to be interviewed. Following the first round of interviews, 2 candidates were invited to a second and final interview with the Board of Directors at its fall Meeting in Winnipeg in October 2018. The Board selected the top candidate who, in January 2019, will become the first CSHP staff officer known as Chief Executive Officer.

During the Social Night hosted by the CSHP Manitoba Branch, immediately following the Fall Board Meeting, I had the honour of delivering tributes to Board members Mario Bédard and Patrick Fitch. Mario completed his term as CSHP Treasurer and Executive Officer. Patrick completed his term as President and began his term as Past-President. At the same meeting, I began my year as President of CSHP.

Within the External Portfolio, I am also responsible for interacting with the CSHP Advocacy Committee and numerous representatives appointed by CSHP to external committees and collaborating organizations. I would like to briefly highlight some of their hard work over the past year.

Advocacy Committee                                                                                                           

Senior Chair: Ryan Itterman

The committee discussed and provided input on a number of topics, including the opioid crisis, medical assistance in dying, national pharmacare, Special Access Programme renewal. The committee conducted a survey of its members, CSHP Board members, and CSHP Branch Executive Officers, the results of which were used to draft an action plan for possible restructuring of the Advocacy Committee and refocus CSHP’s advocacy efforts.

Steering Committee of the Acute Critical Events Simulation (ACES) Education Program of the Royal College of Physicians and Surgeons of Canada (RCPSC)                                    

CSHP Representative: Sharon Yamashita

In March 2018, the first edition of the e-book Navigating Medical Emergencies – An Interactive Guide to Patient Management was published by the Royal College of Physicians and Surgeons of Canada in collaboration with CSHP and other organizations. The e-book is free of charge and can be accessed from the CSHP website at https://www.cshp.ca/clinical-pharmacy. This e-book presents emergent clinical situations and the core tasks healthcare professionals require to recognize, navigate, and safely manage these situations. Included are 55 Clinical Drug Summaries (which fall into 7 different chapters), most of which were written and/or reviewed by CSHP members. Sharon Yamashita, CSHP Representative on this project, provided significant leadership and was listed as a co-editor for the entire publication. CSHP would like to thank the following members who contributed to this e-book: Robert Ariano, Joseph Blais, Paula Brown, Norman Dewhurst, Vincent Ho, Meghan Mackenzie, Marc Perreault, and Sharon Yamashita.

Antimicrobial Stewardship and Resistance Committee, Association of Medical Microbiology and Infectious Disease Canada                                                                                                                                  

CSHP Representative: Tim Lau

This committee continues to focus its work on promoting antimicrobial stewardship practices in Canada through an interdisciplinary and collaborative approach. In the past year, it developed online clinical and educational resources on asymptomatic bacteriuria for physicians, pharmacists, nurses, and patients. Many institutions will be pleased to know the committee has also created an Antimicrobial Stewardship Program Business Case Template available to assist institutions in developing a business proposal for stewardship resources.

Canadian Council for Accreditation of Pharmacy Programs (CCAPP)

CSHP Representative: Donna Woloschuk

CCAPP approved new Accreditation Standards for Canadian Pharmacy Technician Programs as well as a guidance document to assist pharmacy technician programs in implementing the new standards. The publication of the new standards marks a shift in emphasis from evaluation of inputs and outputs to evaluation of outcomes. Changes in curriculum requirements are highly likely to have an impact on institutional pharmacy practice settings that provide student placements. The new accreditation standards for pharmacy technician programs will become effective from July 1, 2019.

Pharmacy Workforce Planning Committee (PWPC), Canadian Pharmacists Association/Association of Faculties of Pharmacy of Canada                                                                                   

CSHP Representative: Douglas Doucette

The group’s mandate is to conduct research, develop recommendations, and advise on key issues related to the development of a modern pharmacy workforce planning model for Canada. Among the number of objectives, the PWPC actions in the past year included formation of the Pharmacy Labour Market Working Group to obtain and analyse data from national and provincial sources and meeting with Health Canada to explore funding opportunities for collecting and planning pharmacy workforce data initiatives.